nextpharma uk topco limited Company Information
Company Number
10823869
Next Accounts
1148 days late
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Shareholders
apollo cv jersey topco limited
apollo cv jersey topco ltd
View AllGroup Structure
View All
Contact
Registered Address
lynton house, 7-12 tavistock square, london, WC1H 9LT
Website
-nextpharma uk topco limited Estimated Valuation
Pomanda estimates the enterprise value of NEXTPHARMA UK TOPCO LIMITED at £428.5m based on a Turnover of £170m and 2.52x industry multiple (adjusted for size and gross margin).
nextpharma uk topco limited Estimated Valuation
Pomanda estimates the enterprise value of NEXTPHARMA UK TOPCO LIMITED at £226.4m based on an EBITDA of £23.6m and a 9.61x industry multiple (adjusted for size and gross margin).
nextpharma uk topco limited Estimated Valuation
Pomanda estimates the enterprise value of NEXTPHARMA UK TOPCO LIMITED at £25m based on Net Assets of £13.8m and 1.81x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Nextpharma Uk Topco Limited Overview
Nextpharma Uk Topco Limited is a live company located in london, WC1H 9LT with a Companies House number of 10823869. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in June 2017, it's largest shareholder is apollo cv jersey topco limited with a 45.6% stake. Nextpharma Uk Topco Limited is a young, mega sized company, Pomanda has estimated its turnover at £170m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Nextpharma Uk Topco Limited Health Check
Pomanda's financial health check has awarded Nextpharma Uk Topco Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
5 Weak
Size
annual sales of £170m, make it larger than the average company (£15.7m)
£170m - Nextpharma Uk Topco Limited
£15.7m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Nextpharma Uk Topco Limited
- - Industry AVG
Production
with a gross margin of 34.7%, this company has a comparable cost of product (34.7%)
34.7% - Nextpharma Uk Topco Limited
34.7% - Industry AVG
Profitability
an operating margin of 8.1% make it more profitable than the average company (4.6%)
8.1% - Nextpharma Uk Topco Limited
4.6% - Industry AVG
Employees
with 1181 employees, this is above the industry average (111)
1181 - Nextpharma Uk Topco Limited
111 - Industry AVG
Pay Structure
on an average salary of £51.8k, the company has a higher pay structure (£37.7k)
£51.8k - Nextpharma Uk Topco Limited
£37.7k - Industry AVG
Efficiency
resulting in sales per employee of £143.9k, this is equally as efficient (£154.3k)
£143.9k - Nextpharma Uk Topco Limited
£154.3k - Industry AVG
Debtor Days
it gets paid by customers after 76 days, this is later than average (47 days)
76 days - Nextpharma Uk Topco Limited
47 days - Industry AVG
Creditor Days
its suppliers are paid after 89 days, this is slower than average (47 days)
89 days - Nextpharma Uk Topco Limited
47 days - Industry AVG
Stock Days
it holds stock equivalent to 57 days, this is more than average (37 days)
57 days - Nextpharma Uk Topco Limited
37 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 5 weeks, this is less cash available to meet short term requirements (12 weeks)
5 weeks - Nextpharma Uk Topco Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 94.6%, this is a higher level of debt than the average (71.2%)
94.6% - Nextpharma Uk Topco Limited
71.2% - Industry AVG
NEXTPHARMA UK TOPCO LIMITED financials
Nextpharma Uk Topco Limited's latest turnover from December 2019 is £170 million and the company has net assets of £13.8 million. According to their latest financial statements, Nextpharma Uk Topco Limited has 1,181 employees and maintains cash reserves of £6.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2019 | Dec 2018 | Dec 2017 | |
---|---|---|---|
Turnover | 169,976,530 | 153,276,765 | 49,872,235 |
Other Income Or Grants | 0 | ||
Cost Of Sales | 40,355,979 | ||
Gross Profit | 9,516,257 | ||
Admin Expenses | 5,551,150 | ||
Operating Profit | 13,811,157 | 8,575,555 | 3,965,107 |
Interest Payable | 9,749,052 | 9,117,169 | 2,731,518 |
Interest Receivable | 0 | 0 | 0 |
Pre-Tax Profit | 4,062,105 | -541,614 | -7,225,306 |
Tax | 180,538 | -3,069,146 | 2,202,837 |
Profit After Tax | 4,242,643 | -3,610,760 | -5,022,469 |
Dividends Paid | 0 | 0 | 0 |
Retained Profit | 4,242,643 | -3,610,760 | -5,022,469 |
Employee Costs | 61,202,383 | 52,175,483 | 15,684,201 |
Number Of Employees | 1,181 | 1,048 | 1,031 |
EBITDA* | 23,560,209 | 17,512,186 | 6,167,943 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2019 | Dec 2018 | Dec 2017 | |
---|---|---|---|
Tangible Assets | 88,192,815 | 54,432,208 | 51,898,846 |
Intangible Assets | 89,366,312 | 86,477,704 | 85,646,312 |
Investments & Other | 0 | 90,269 | 0 |
Debtors (Due After 1 year) | 4,693,988 | 4,513,450 | 4,141,334 |
Total Fixed Assets | 177,559,126 | 140,909,911 | 137,545,158 |
Stock & work in progress | 17,512,186 | 14,081,964 | 13,833,817 |
Trade Debtors | 35,565,987 | 29,788,771 | 0 |
Group Debtors | 0 | 0 | 0 |
Misc Debtors | 16,880,303 | 9,839,321 | 28,636,884 |
Cash | 6,589,637 | 8,756,093 | 13,745,704 |
misc current assets | 0 | 0 | 0 |
total current assets | 76,548,113 | 62,466,149 | 56,216,407 |
total assets | 254,107,239 | 203,376,060 | 193,761,565 |
Bank overdraft | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 |
Trade Creditors | 27,351,507 | 24,101,823 | 34,276,148 |
Group/Directors Accounts | 0 | 0 | 0 |
other short term finances | 5,686,947 | 3,520,491 | 5,551,149 |
hp & lease commitments | 5,416,140 | 1,624,842 | 0 |
other current liabilities | 19,407,835 | 10,561,473 | 440,567 |
total current liabilities | 57,862,430 | 39,808,630 | 40,267,865 |
loans | 305,470,300 | 245,712,222 | 231,386,024 |
hp & lease commitments | 19,678,642 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 |
other liabilities | 2,527,532 | 4,062,105 | 15,243,633 |
provisions | 54,341,938 | 49,467,412 | 18,680,058 |
total long term liabilities | 182,433,652 | 151,651,922 | 141,334,038 |
total liabilities | 240,296,082 | 191,460,552 | 181,601,903 |
net assets | 13,811,157 | 11,915,508 | 12,159,662 |
total shareholders funds | 13,811,157 | 11,915,508 | 12,159,662 |
Dec 2019 | Dec 2018 | Dec 2017 | |
---|---|---|---|
Operating Activities | |||
Operating Profit | 13,811,157 | 8,575,555 | 3,965,107 |
Depreciation | 6,048,023 | 7,221,520 | 1,674,156 |
Amortisation | 3,701,029 | 1,715,111 | 528,680 |
Tax | 180,538 | -3,069,146 | 2,202,837 |
Stock | 3,430,222 | 248,147 | 13,833,817 |
Debtors | 12,998,736 | 11,363,323 | 32,778,218 |
Creditors | 3,249,684 | -10,174,324 | 34,276,148 |
Accruals and Deferred Income | 8,846,362 | 10,120,906 | 440,567 |
Deferred Taxes & Provisions | 4,874,526 | 30,787,354 | 18,680,058 |
Cash flow from operations | 24,282,361 | 33,565,506 | 15,155,518 |
Investing Activities | |||
capital expenditure | |||
Change in Investments | -90,269 | 90,269 | 0 |
cash flow from investments | |||
Financing Activities | |||
Bank loans | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 |
Other Short Term Loans | 2,166,456 | -2,030,658 | 5,551,149 |
Long term loans | 59,758,078 | 14,326,198 | 231,386,024 |
Hire Purchase and Lease Commitments | 23,469,940 | 1,624,842 | 0 |
other long term liabilities | -1,534,573 | -11,181,528 | 15,243,633 |
share issue | |||
interest | -9,749,052 | -9,117,169 | -2,731,518 |
cash flow from financing | 71,763,855 | -3,011,708 | 266,631,419 |
cash and cash equivalents | |||
cash | -2,166,456 | -4,989,611 | 13,745,704 |
overdraft | 0 | 0 | 0 |
change in cash | -2,166,456 | -4,989,611 | 13,745,704 |
nextpharma uk topco limited Credit Report and Business Information
Nextpharma Uk Topco Limited Competitor Analysis
Perform a competitor analysis for nextpharma uk topco limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other mega companies, companies in WC1H area or any other competitors across 12 key performance metrics.
nextpharma uk topco limited Ownership
NEXTPHARMA UK TOPCO LIMITED group structure
Nextpharma Uk Topco Limited has 1 subsidiary company.
Ultimate parent company
APOLLO CV JERSEY TOPCO LTD
#0110559
2 parents
NEXTPHARMA UK TOPCO LIMITED
10823869
1 subsidiary
nextpharma uk topco limited directors
Nextpharma Uk Topco Limited currently has 4 directors. The longest serving directors include Mr Othmane Khelladi (Jun 2017) and Mr Christopher Campbell (Jun 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Othmane Khelladi | England | 38 years | Jun 2017 | - | Director |
Mr Christopher Campbell | United Kingdom | 51 years | Jun 2017 | - | Director |
Mr Jason Rodrigues | England | 42 years | Jun 2017 | - | Director |
Mr Peter Burema | England | 66 years | Oct 2017 | - | Director |
P&L
December 2019turnover
170m
+11%
operating profit
13.8m
+61%
gross margin
34.8%
+3.09%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2019net assets
13.8m
+0.16%
total assets
254.1m
+0.25%
cash
6.6m
-0.25%
net assets
Total assets minus all liabilities
nextpharma uk topco limited company details
company number
10823869
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
June 2017
age
7
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2019
previous names
apollo uk topco limited (October 2017)
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
lynton house, 7-12 tavistock square, london, WC1H 9LT
Bank
-
Legal Advisor
-
nextpharma uk topco limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to nextpharma uk topco limited.
nextpharma uk topco limited Companies House Filings - See Documents
date | description | view/download |
---|